BioWorld Science

July 16, 2014

View Archived Issues

A*STAR partners with Roche in cancer

Read More

Merck & Co. patents novel HIV integrase inhibitors

Read More

Actelion presents novel P2X7 receptor antagonists

Read More

Grant supports DiamiR's work on brain-enriched microRNA biomarkers for Parkinson's disease

Read More

Ratiopharm claims new MMF prodrugs

Read More

Almirall patents novel dual beta2 agonists and M3 antagonists

Read More

Serum peptide signature detects early-stage lung cancer

Read More

Gene signature correlated with prognosis in colorectal cancer

Read More

Novel agents for cancer and infections reported by the University of Washington

Read More

Purdue Pharma patents new Na(v)1.7 channel blockers

Read More

C4T discloses new cannabinoid CB2 receptor agonists

Read More

Takeda Pharmaceutical discloses novel DAAO inhibitors

Read More

Ventrus Biosciences becomes Assembly Biosciences

Read More

PharmaMar and Chugai enter into license agreement in Europe for Aplidin

Read More

Treatment with PF-05231023 improves lipid parameters in patients with type 2 diabetes

Read More

ZS Pharma completes enrollment in second phase III study of ZS-9 in hyperkalemia

Read More

Abbott to sell part of generics business to Mylan

Read More

AstraZeneca's proton pump inhibitor enters pediatric phase I/II clinical trial

Read More

BioChaperone Combo shows promising PK/PD profile in early clinical trials

Read More

Novartis collaborates with Banner Alzheimer's Institute on AD prevention study

Read More

SBIR grant supports Cel-Sci's development of LEAPS technology for RA

Read More

Neos Therapeutics reports phase III findings for NT-0102

Read More

FDA grants priority review to sNDA for simeprevir in combination with sofosbuvir

Read More

GSK and Theravance initiate phase III program of triple combination treatment for COPD

Read More

Nymox completes enrollment in second re-injection study of NX-1207 for BPH

Read More